MULTIDISCIPLINARY COLLABORATION IN DEVELOPING AN ALERT THERAPY HEMODYNAMIC DEVICE FOR HALLUCINATION PATIENTS: AN EVIDENCE-BASED NURSING INNOVATION

KOLABORASI MULTIDISIPLIN DALAM PENGEMBANGAN ALAT TERAPI PERINGATAN DINI HEMODINAMIK BAGI PASIEN HALUSINASI: INOVASI KEPERAWATAN BERBASIS BUKTI

https://doi.org/10.36082/jhcn.v5i2.2764

Authors

  • Heni Nurhaeni Program Studi Prodi Sarjana Terapan & Profesi Ners, Politeknik Kesehatan Kemenkes Jakarta I, Jakarta, Indonesia
  • Hikmawati Nurokhmanti Program Studi Pendidikan Kedokteran, Fakultas Kedokteran, Universitas Gadjah Mada, Yogyakarta, Indonesia

Keywords:

Gangguan jiwa, Halusinasi, Hemodinamik, Self Efficacy, Tim Disiplin

Abstract

Severe mental disorders such as schizophrenia can cause autonomic nervous system dysfunction, leading to hemodynamic changes including increased heart rate, elevated blood pressure, and decreased heart rate variability. These physiological changes often appear before hallucinations, indicating the need for early detection technology based on physiological signals to prevent symptom escalation. This study developed the Hemodynamic Early Warning System (Alert Therapy Hemodynamic) to detect pre-hallucination hemodynamic patterns and to strengthen patient self-efficacy. The study used a simplified Borg & Gall Research and Development (R&D) model, consisting of five stages: needs identification, system design, prototype development, user testing, and revision. The prototype was created through multidisciplinary collaboration and includes multimodal sensors (HR, HRV, blood pressure), a pattern-detection algorithm, and a biofeedback module. Initial user testing evaluated function, comfort, and usability using the Functionality, Usability, Look-and-Feel, Evaluation (FULE) approach. The results showed that the pre-hallucination hemodynamic patterns were consistent with the literature, and the prototype functioned well and was accepted by users. This innovation is important for nurses, who play a key role in early detection of patient condition changes and in preventing symptom worsening. The system has the potential to improve recognition of early physical signs, enhance patient self-control, and increas clinical safety. Considering this urgency, future studies should include pre-clinical and limited clinical trials to assess the effectiveness, efficiency, and safety of this real-time HR/HRV-based pre-hallucination early detection tool in real patient populations.

Downloads

Download data is not yet available.

References

Ali, S. A., Mathur, N., Malhotra, A. K., & Braga, R. J. (2019). Electroconvulsive Therapy and Schizophrenia: A Systematic Review. Complex Psychiatry, 5(2), 75–83. https://doi.org/10.1159/000497376

Correll, C. U., Solmi, M., Veronese, N., Bortolato, B., & Carvalho, A. F. (2022). Cardiometabolic risk in patients with schizophrenia and related disorders: A meta-analysis. The Lancet Psychiatry, 9(3), 198–210. https://doi.org/10.1016/S2215-0366(21)00420-5

Jaftoran, E. A., Keliat, B. A., & Wardani, I. Y. (2021). Nursing intervention, family’s role, cadre’s role and medical services: Case series on client with hallucination and self-care deficit. Enferm. Clin., 31(Suppl 2), S180–S184. https://doi.org/10.1016/j.enfcli.2020.12.018

Liberman-Pincu, E., & Bitan, Y. (2021). FULE—Functionality, usability, look-and-feel, and evaluation: A user-centered product design methodology illustrated in the case of an autonomous medical device. Applied Sciences, 11(3), 985. https://doi.org/10.3390/app11030985

Markiewicz, A., & Gospodarek, E. (2023). Self-regulatory neuronal mechanisms and long-term cardiovascular challenges in schizophrenia treatment. Brain Sciences, 13(4), 651. https://doi.org/10.3390/brainsci13040651

Perrottelli, A., Giordano, G. M., Brando, F., Giuliani, L., & Mucci, A. (2021). EEG-based measures in at-risk mental state and early stages of schizophrenia: A systematic review. Frontiers in Psychiatry, 12, 653642. https://doi.org/10.3389/fpsyt.2021.653642

Ringen, P. A., Engh, J. A., Birkenaes, A. B., Dieset, I., & Andreassen, O. A. (2018). Cardiometabolic risk factors in schizophrenia spectrum disorders: Systematic review and clinical recommendations. Journal of Clinical Psychiatry, 79(2), 17–25. https://doi.org/10.4088/JCP.16r10712

Sueyoshi, K., & Sumiyoshi, T. (2018). Electrophysiological evidence in schizophrenia in relation to treatment response: A review. Frontiers in Psychiatry, 9, 259. https://doi.org/10.3389/fpsyt.2018.00259

Vaseghi, S., Nasehi, M., & Zarrindast, M. R. (2021). How cannabinoids modulate memory processing via neurotransmitter systems: Implications for psychosis and cardiovascular regulation. Neuroscience & Biobehavioral Reviews, 120, 173–221. https://doi.org/10.1016/j.neubiorev.2020.10.018

Zhao, X., Wang, H., Liu, Y., & Chen, Y. (2020). Heart rate variability as a biomarker of psychophysiological stress in schizophrenia: A systematic review and meta-analysis. Psychiatry Research, 290, 113092. https://doi.org/10.1016/j.psychres.2020.113092

Wang, C., Ma, H., Sun, J., & Wu, Z. (2023). Biofeedback-based mobile applications for anxiety and psychotic symptoms: A scoping review. International Journal of Environmental Research and Public Health, 20(5), 3941. https://doi.org/10.3390/ijerph20053941

World Health Organization (2023). Comprehensive mental health action plan 2013–2030: Progress report. Geneva: WHO. Retrieved from https://www.who.int/publications/i/item/9789240072982

Published

2025-12-06